Skip to content

Clinical trials

Expanded access Breast Neoplasms trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Breast Neoplasms Phase: Expanded access Clear all

19 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20101
20111

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
No longer available7
Approved for marketing6
Available5
Temporarily not available1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company4
Novartis Pharmaceuticals4
Genentech, Inc.2
AIO-Studien-gGmbH1
AVM Biotechnology Inc1
Aveni Foundation1
Eisai Inc.1
Merus B.V.1
Novartis1
Sanofi1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Breast Neoplasms19
Pancreatic Neoplasms5
Carcinoma, Non-Small-Cell Lung4
Prostatic Neoplasms4
Ovarian Neoplasms3
Brain Neoplasms2
Carcinoma, Renal Cell2
Colorectal Neoplasms2
Neoplasms2
Sarcoma2

Trials

Showing 51 to 19 of 19. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.